Bragar Eagel & Squire, PC reminds investors that a class action lawsuit has been filed against AstraZeneca PLC and urges investors to contact the industry
EMA issues advice on the use of regdanvimab monoclonal anti-COVID-19 antibody treatment at Celltrion (CT-P59) for COVID-19 patients in the European Union
/https://specials-images.forbesimg.com/imageserve/605e872fa1eb6f5c529d9140/0x0.jpg?fit=300%2C300&ssl=1 "Amazon gets emergency FDA approval for Covid-19 At-Home Test Kit")
